In the Mix: 10 More Articles — April 13, 2026

In the Mix: 10 More Articles — April 13, 2026

In the Mix: 10 More Articles — April 13, 2026
In the Mix — Last 24 Hours
April 13, 2026. 10 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score.
#25

Weekly Roundup on the Cannabis Sector & Psychedelic Sector – Yahoo Finance

This article provides a weekly sector overview covering cannabis and psychedelic industry developments, legal changes, and therapeutic applications relevant to clinicians monitoring market and research trends.

Read more →
#25

The "Benjamin Button" Effect: Does Cannabis REVERSE Brain Aging? (New 2025 Study)

This article discusses a 2025 study examining potential cannabis effects on brain aging biomarkers, which may interest clinicians tracking emerging neuroscience research relevant to patient education and long-term health considerations.

Read more →
#25

What to know about THC restrictions in Casper and across Wyoming

This article covers local THC product restrictions in Casper, Wyoming and store closures due to declining sales, relevant to clinicians monitoring regulatory landscape changes affecting patient access.

Read more →
#25

Kanna With THC: The Mood-Boosting Combo Explained – VICE

This article describes a commercial product combining kanna with hemp-derived THC, which may interest clinicians tracking emerging cannabinoid product formulations and marketing claims.

Read more →
#25

The Hemp Industry Is Being Killed By Market Consolidation Disguised As Consumer …

This article discusses market consolidation in the hemp industry and its effects on consumers, which may interest clinicians monitoring cannabis industry dynamics affecting product availability and pricing.

Read more →
#15

Trulieve to Open Medical Cannabis Dispensary in Boca Raton, Florida – The Globe and Mail

Trulieve’s new dispensary opening in Boca Raton represents continued expansion of medical cannabis retail infrastructure in Florida, which may inform clinicians about local patient access and market availability.

Read more →
#15

Alexandria man arrested on fourth OWI charge | Rapides Parish Journal

Local arrest report documenting drug possession charges including marijuana; may interest clinicians monitoring substance use patterns in their community or patient populations.

Read more →
#5

RELM LAUNCHES KIDNAP AND RANSOM INSURANCE FOR DIGITAL ASSET … – Markets Insider

Summary This article covers insurance products for digital asset protection, mentioning cannabis operators among diverse clientele navigating security threats in emerging business sectors.

Read more →
#5

Love County deputies have seized over 600lbs of marijuana in the span of just over a month …

Summary Law enforcement seizure reports documenting cannabis cultivation operations may interest clinicians tracking regional supply disruption patterns and their potential effects on patient access to legal cannabis products.

Read more →
#5

John Morgan isn’t running for Governor, but you can win $100K for naming his new political party

Article Summary This article discusses cannabis advocate John Morgan’s decision not to pursue gubernatorial office while launching a new political party, which may interest clinicians tracking cannabis policy advocacy developments.

Read more →

Digest-Level Clinical Commentary

Dr. Caplan’s Take
These items collectively signal a sector in transition between speculative growth and regulatory maturation, where clinical cannabis medicine practitioners must navigate simultaneously widening access in some jurisdictions, tightening restrictions in others, and persistent public confusion about therapeutic versus recreational applications. The prominence of emerging research claims like “brain aging reversal” alongside enforcement actions and market consolidation suggests I need to maintain stricter evidence standards in my practice, as patients will increasingly encounter sensationalized claims while legitimate medical access remains inconsistently available. The fragmented regulatory landscape also indicates that my clinical recommendations must remain geographically sensitive and tethered to established cannabinoid pharmacology rather than market-driven product trends.
Clinical Perspective

These items reflect the cannabis industry’s ongoing maturation and fragmentation: commercialization is advancing through retail expansion and product innovation, while regulatory uncertainty and market consolidation are creating operational challenges for smaller operators. A concurrent trend involves emerging research into cannabis’s neurobiological effects, though claims about reversing brain aging require careful scrutiny given the current state of evidence. Law enforcement activity remains substantial despite shifting legal landscapes, indicating persistent tensions between legalization in some jurisdictions and enforcement priorities in others.

Cannabis RegulationCannabis BusinessCannabis ResearchLaw Enforcement

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

FAQ

This News item was assembled from structured source metadata and pipeline scoring.

Have thoughts on this? Share it: